Health officials reported that cases of human metapneumovirus (HMPV) spiked this spring as COVID-19 and Respiratory Syncytial Virus cases fell. National data from the Centers for Disease Control ...

WHAT WE FOUND Human Metapneumovirus (HMPV) is not new. The respiratory virus was first identified in 2001, according to the Centers for Disease Control and Prevention.

Cases of human metapneumovirus or HMPV, a common but lesser-known respiratory virus, surged in the U.S. this spring. Here's what to know about symptoms and transmission.

In China, HMPV ranked eighth among the eight viruses that cause acute respiratory infections, with a positive rate of 4.1 percent, which is far lower than the 28.5 percent rate of the influenza virus.

Sanofi SA (NASDAQ:SNY) on Tuesday agreed to acquire Vicebio Ltd, a privately held biotechnology company headquartered in ...

The human metapneumovirus (hMPV) is not new in China or elsewhere in the world, its recent spike in China is within the usual range for winter and there is no evidence that China has declared a ...

The deal complements an existing partnership with Novavax that encompasses R&D of combination vaccines for Covid-19 and flu.

Yes, folks, 2023 saw yet another case of a respiratory virus surging beyond what it normally does. The influenza and respiratory syncytial viruses spiked much higher this winter than in previous ...

In addition to Zhu, authors of the study, "Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus," include Yi-Zong Lee, Jerome Han ...

Research focuses on the design of a multi-epitope polyvalent vaccine against Human Respiratory Syncytial Virus (RSV), a leading cause of lower respiratory tract infections. The study utilizes ...